Pure Global AI
HPRA · Europe

Ireland medical device regulatory resources

Every Ireland dataset, comparison, and AI workpaper we maintain — one entry point for the whole market.

5 free resources23/25 topics with recordsAug 2026 fees reviewed
Run the classification agent

Everything we track for Ireland

Medical device regulation news

Follow recent Health Products Regulatory Authority (HPRA) policy, guidance, safety, and compliance updates.

AI medical device classifier

Describe your device and get a preliminary HPRA risk class with official rule references.

Government registration fees

Review current HPRA application, review, and renewal fees.

Additional certification and licence checker

Check whether product features may trigger separate radio, electrical, metrology, radiation, import, or other Ireland requirements.

Registration timeline

Compare the statutory notified-body conformity assessment clock under Regulation (EU) 2026/977 with realistic CE marking times by device class.

Structured regulatory requirements

Explore all 39 source-linked facts →

23 of 25 research dimensions currently covered · 28 official sources · latest verification 2026-09-15

Market entry

D01

Authority & regime

Verified
Competent authority
The Health Products Regulatory Authority (HPRA) is Ireland's competent authority for medical devices: S.I. No. 261 of 2021 defines 'Authority' as the HPRA and assigns it the State functions…
Enforcement mandate
The Medical Devices Regulations 2021 and the MDR provisions they refer to are enforced by HPRA.
3 source-linked facts
Checked 2026-08-25
Open details →
D02

Legal basis & guidance

Verified
MDR transposition law
Ireland's MDR implementation law is the Medical Devices Regulations 2021 (S.I. No. 261 of 2021), made under section 32 of the Irish Medicines Board Act 1995, in operation from 26 May 2021,…
1 source-linked fact
Checked 2026-08-25
Open details →
D03

Device definition & scope

Verified
IVD registration scope excludes in-house devices
For Irish national IVD registration, 'device' means an in vitro diagnostic medical device or IVD accessory and expressly excludes in house devices and products excluded by IVDR Article 1(3)…
1 source-linked fact
Checked 2026-08-25
Open details →
D04

Classification rules

Verified
EU MDR classes I, Is, Im, Ir, IIa, IIb and III
Class I, Class Is, Class Im, Class Ir, Class IIa, Class IIb, Class III
1 maintained scheme
Checked 2026-08-26
Open details →
D05

Registration pathways

Verified
National IVD operator registration including importers and distributors
For IVDs, Irish established manufacturers, authorised representatives, importers and distributors must all notify HPRA (name and place of business; manufacturer details for importers; devic…
National manufacturer and AR registration (medical devices)
Manufacturers established in Ireland must notify HPRA of their name, registered place of business and a device identifying description; manufacturers designating an Irish authorised represe…
2 source-linked facts
Checked 2026-08-25
Open details →
D06

Reliance & recognition

Verified
NMPA certificate does not replace EU conformity assessment
statement: For ordinary market placement under MDR/IVDR, a Chinese approval does not replace conformity assessment under MDR Article 52 or IVDR Article 48. The applicable EU class and proce…
EU CE under MDR/IVDR — single market validity
target: geo:irl · sourceApproval: EU CE under MDR/IVDR · edgeType: single market validity · marketAccessStrength: direct · regulatoryLayer: product marketing · sameDeviceRequired: Yes · loc…
2 source-linked facts
Checked 2026-09-15
Open details →
D07

Economic-operator roles

Verified
Authorised representative designation evidence
An authorised representative established in Ireland must, when registering with HPRA, furnish sufficient evidence that it has been designated by the manufacturer for the device concerned (i…
1 source-linked fact
Checked 2026-08-25
Open details →
D08

Establishment, import & distribution

Verified
Distributor registration (medical devices)
Distributors established in Ireland who place medical devices (other than IVDs) on the market must notify HPRA of their name, registered place of business and the device category — a nation…
Manufacturing facility notification
'Manufacturing facilities' in Ireland — entities that do not place devices on the market under their own name but manufacture devices or critical components, or carry out packaging or label…
2 source-linked facts
Checked 2026-08-25
Open details →
D09

Dossier requirements

Verified
Technical documentation (Annexes II and III)
The technical documentation required to demonstrate conformity with the general safety and performance requirements must be drawn up in accordance with Annex II to Regulation (EU) 2017/745…
1 source-linked fact
Checked 2026-08-29
Open details →
D10

Official forms & portals

Verified
Clinical investigation submission via CESP
Clinical investigation applications and notifications (MDR Art. 62/74/82) are submitted to HPRA through the Common European Submission Portal (CESP), followed by an email to devices@hpra.ie…
Performance study submission via CESP
IVDR performance study applications and notifications are submitted to HPRA via CESP with an email to devices@hpra.ie quoting the CESP reference number; substantial modifications to approve…
3 source-linked facts
Checked 2026-08-25
Open details →

Submission & evidence

D11

Label, IFU & language

Verified
Implant card deadline for health institutions
An Irish health institution that implants an implantable device must give the patient the MDR Article 18(1) information and the implant card bearing the patient's identity as soon as possib…
1 source-linked fact
Checked 2026-08-25
Open details →
D12

QMS, audit & inspection

Verified
HPRA inspections of device actors
HPRA assesses notified bodies and inspects manufacturers, authorised representatives, distributors, importers, manufacturing facilities, suppliers to manufacturers and third country sites;…
1 source-linked fact
Checked 2026-08-25
Open details →
D13

Standards, testing & ancillary approvals

Unresolved
MDR electrical safety in place of the Low Voltage Directive
Electrical safety
MDR electromagnetic compatibility in place of the EMC Directive
EMC
European Union (Radio Equipment) Regulations 2026
Wireless / radio
7 maintained overlays
Open details →
D14

Fees

Verified
Manufacturer establishment registration (code 431)
EUR 150
Annual manufacturer fee by employee count (codes 458–462, 470)
EUR 275–33,430
15 maintained fee lines · 1 related fact
Checked 2026-08-25
Open details →
D15

Review clocks

Unresolved
Class I · Self-declaration (no notified body)
0 days
1 maintained pathway · 1 related fact
Checked 2026-08-29
Open details →
D16

Approval validity & renewal

Verified
Annual maintenance fee cycle for registered operators
National device registration carries an annual maintenance fee for all registered economic operators (whether registered via EUDAMED or directly with HPRA), invoiced in quarter 2 of each ye…
1 source-linked fact
Checked 2026-08-25
Open details →

Lifecycle & post-market

D17

Change control

Verified
Substantial modification of a clinical investigation
Substantial modifications to an ongoing clinical investigation must be notified to HPRA for assessment before implementation (Notification of Substantial Modification form, submitted via th…
Substantial modification of a performance study
Substantial modifications to HPRA approved IVD performance studies are notified per IVDR Article 71 via CESP using the Appendix 2 format of AUT G0176 2 (description, justification, impact,…
2 source-linked facts
Checked 2026-08-25
Open details →
D18

UDI, listing & traceability

Verified
Unique Device Identification system (Art. 27)
Devices other than custom made and investigational devices carry a Unique Device Identification consisting of a UDI device identifier (UDI DI) specific to a manufacturer and a device and a…
1 source-linked fact
Checked 2026-08-29
Open details →
D19

Clinical investigation & performance

Verified
Article 62 investigation cannot start before HPRA authorisation
A sponsor must not start a clinical investigation of the Article 62 type in Ireland until HPRA has notified the sponsor of its authorisation within the period referred to in MDR Article 70(…
NREC-MD ethics approval required
All clinical investigations in Ireland must receive ethics approval from the National Research Ethics Committee for Medical Devices (NREC MD) before starting; the NREC MD review is independ…
5 source-linked facts
Checked 2026-08-25
Open details →
D20

Special access & derogation

Verified
Genetic test information and counselling requirement
Ireland exercised the IVDR Article 4(3) option: where a genetic test is used on an individual in the context of healthcare, the individual (or legally designated representative) must be pro…
Single-use device reprocessing condition
A person may not reprocess a single use device to make it suitable for further use in Ireland unless there is compliance with MDR Article 17(6), (7) and (8); a reprocessor assumes the oblig…
2 source-linked facts
Checked 2026-08-25
Open details →
D21

Manufacturer PMS

Verified
Post-market surveillance reporting (Arts. 83-86)
Manufacturers must implement a post market surveillance system (Art. 83) and a documented post market surveillance plan proportionate to the risk class and appropriate to the type of device…
1 source-linked fact
Checked 2026-08-29
Open details →
D22

Vigilance & incident reporting

Verified
National vigilance reporting channel
Manufacturers and authorised representatives submit vigilance reports to HPRA by email at devicesafety@hpra.ie (national channel alongside EUDAMED); the vigilance requirements are those of…
Importer/distributor serious-risk and falsified-device duty
An importer or distributor in Ireland that suspects a device presents a serious risk, or is a falsified device, must inform HPRA at once by email at devicesafety@hpra.ie.
2 source-linked facts
Checked 2026-08-25
Open details →
D23

Recall, FSCA & market surveillance

Verified
Enforcement notices and 7-day court appeals
HPRA market surveillance enforcement tools under S.I. 261 of 2021 include quarantine notices, compliance notices and prohibition orders (regs. 31 33); an appeal against a compliance notice…
1 source-linked fact
Checked 2026-08-25
Open details →
D24

Advertising, claims & promotion

Verified
Misleading claims prohibition (Art. 7)
In the labelling, instructions for use, making available, putting into service and advertising of devices it is prohibited to use text, names, trade marks, pictures and figurative or other…
1 source-linked fact
Checked 2026-08-29
Open details →
D25

Submission communications & appeal

Verified
Clinical investigation appeal within 28 days
A sponsor may appeal HPRA decisions within 28 days of receipt: refusal of clinical investigation authorisation (MDR Art. 70(3)), decisions under Art. 71(4), and refusal of substantial modif…
HPRA appeal route via Advisory Committee
HPRA appeals for clinical investigation objections (and clinical trial non acceptances) are submitted to the relevant statutory Advisory Committee within 28 days of notification and decided…
3 source-linked facts
Checked 2026-08-25
Open details →

Government fees

Full fee schedule (15 lines) →

HPRA registration fees in EUR · reviewed 2026-08-25

Fee lineAmountProvenance
Manufacturer establishment registration (code 431)EUR 150Verified
Annual manufacturer fee by employee count (codes 458–462, 470)EUR 275–33,430Verified
Annual authorised-representative fee - Type IEUR 1,200Verified
Annual authorised-representative fee - Type IIEUR 1,635Verified
11 more fee lines on the full schedule · 15 of 15 rows source-verified

Registration timeline

Full registration timeline →

Health Products Regulatory Authority (HPRA) review clocks and planning ranges · 4-class (I, IIa, IIb, III) — EU MDR classification

Class / pathwayReview clockPlanning totalProvenance
Class I(Self-declaration (no notified body))0 days6-9 monthsVerified
  1. 1Pre-Submission Preparation(1-3 months)
  2. 2Application Submission(1-2 weeks)
  3. 3Administrative Review(2-4 weeks)
  4. 4Technical Evaluation(0 days)
  5. 5Registration Approval(1-2 weeks)

Latest regulation news

All Ireland regulation news →

Newest official HPRA headlines from the daily-refreshed feed — every row links directly to the authority publication.

Sep 3HPHealth Products Regulatory Authority (HPRA)HPRA Safety Notices: Medical Device Field Safety Notices SummariesIrelandSep 3HPHealth Products Regulatory Authority (HPRA)HPRA Summary of Medical Device Field Safety Notices: July 2026IrelandSep 3HPHealth Products Regulatory Authority (HPRA)HPRA Summary of Medical Device Field Safety Notices: August 2026IrelandJul 21HPHealth Products Regulatory Authority (HPRA)OMNI-TRACT Vaginal Deaver Retractor, smallIreland
Continue with this market

Turn Ireland research into practical work

The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.

View every AI workpaper →

Build a reusable product master

Structure company, product, model, approval, certificate, and evidence facts before starting Ireland work.

Ireland market-launch workpaper

Connect the HPRA route, evidence, labels, local role, timing, and dependencies to a wider launch plan.

Ireland dossier reuse and delta

Compare an existing authorization and evidence set against HPRA administrative, testing, labeling, and dossier needs.

Ireland change notification workpaper

Map a product or manufacturing change to HPRA evidence, notification, timing, and implementation questions.

Ireland regulatory change impact

Assess a current HPRA update against one product and turn it into an owner-ready action workpaper.

Ireland cybersecurity evidence review

Review connected-device architecture, risks, SBOM, testing, lifecycle controls, and market-specific questions for Ireland (HPRA).

Country hubs in other markets

Other Europe markets

AlbaniaArmeniaAustriaAzerbaijanBelarusBelgiumBosnia and HerzegovinaBulgariaCroatiaCyprusCzech RepublicDenmarkEstoniaEuropean UnionFinlandFranceGeorgiaGermanyGreeceHungaryIcelandItalyKazakhstanLatviaLiechtensteinLithuaniaLuxembourgMaltaMoldovaMontenegroNetherlandsNorth MacedoniaNorwayPolandPortugalRomaniaRussiaSerbiaSlovakiaSloveniaSpainSwedenSwitzerlandTurkeyUkraineUnited KingdomAll 114 markets →
DJ Fang
Entering the Ireland market?
Local representation, HPRA submissions, and lifecycle maintenance — handled with an expert.
Pricing